Two lines of painkillers are to be removed from the New Zealand market.
Paradex and Capadex contain the drug dextropropoxyphene.
Medsafe says it is pulling the medicines after a review into their safety and efficiency found their risks outweigh their benefits.
General manager Stewart Jessamine says the drugs will be removed gradually to allow time patients to switch.
He says anyone taking the drugs should finish their course, while those who take them regularly should talk to their GP about possible alternatives.
- NEWSTALK ZB
AdvertisementAdvertise with NZME.
Latest from New Zealand
Former Te Whatu Ora chair criticises Health NZ’s ‘savings’ directive
Rob Campbell said it shows "poor management" and is "frankly irresponsible".